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Both cross-presentation of antigens by dendritic
cells, a key pathway triggering T cell immunity and
immune tolerance, and survival of several pathogens
residing in intracellular vacuoles are intimately linked
to delayedmaturation of vesicles containing internal-
ized antigens and microbes. However, how early en-
dosome or phagosome identity is maintained is
incompletely understood. We show that Toll-like re-
ceptor 4 (TLR4) and Fc receptor ligation induces
interaction of the GTPase Rab14 with the kinesin
KIF16b mediating plus-end-directed microtubule
transport of endosomes. As a result, Rab14 recruit-
ment to phagosomes delays their maturation and
killing of an internalized pathogen. Enhancing
anterograde transport by overexpressing Rab14,
promoting the GTP-bound Rab14 state, or inhibiting
retrograde transport upregulates cross-presenta-
tion. Conversely, reducing Rab14 expression, desta-
bilizing Rab14 endosomes, and inhibiting antero-
grade microtubule transport by Kif16b knockdown
compromise cross-presentation. Therefore, regula-
tion of early endosome trafficking by innate immune
signals is a critical parameter in cross-presentation
by dendritic cells.INTRODUCTION
Endocytosis, the active uptake of extracellular molecules, is
used by all cells to sense, exploit, and interact with their envi-
ronment. In myeloid cells of the immune system, endocytosis
fulfills the additional functions of pathogen sensing and3568 Cell Reports 24, 3568–3581, September 25, 2018 ª 2018 The A
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nalized material for presentation by major histocompatibility
complex (MHC) molecules. These functions are regulated by
a process referred to as maturation of the vesicles containing
internalized material (Huotari and Helenius, 2011). Vesicle
maturation is the result of a series of ‘‘kiss-and-run’’ fusion
and fission events between incoming and various intracellular
vesicles. These events change the protein composition and
pH of the former, eventually creating an acidic vesicle equip-
ped for efficient and rapid degradation of all internalized
biomolecules.
Cross-presentation, defined as the presentation byMHCclass
I molecules of peptides derived from internalized material, is one
of the molecular events regulated by maturation (Cruz et al.,
2017). Efficient cross-presentation depends on a delayed and/
or attenuated maturation of vesicles containing antigenic mate-
rial, thought to inhibit rapid destruction of internalized proteins
and preserve antigenic information (Alloatti et al., 2016). Consis-
tent with this, the speed of vesicle maturation is inversely corre-
latedwith the efficacy of cross-presentation, with a gradient from
conventional dendritic cells (cDCs), cross-presenting with the
highest efficacy, to macrophages and neutrophils (Amigorena
and Savina, 2010).
Given that vesicle maturation transforms ‘‘early’’ to ‘‘late’’ ves-
icles, the prevalent concept is that an early endosome or phag-
osome environment is favorable for cross-presentation. In sup-
port of this, the efficacy of cross-presentation is inversely
correlated with the expression of transcription factor EB (TFEB)
in dendritic cells (DCs), a transcription factor enhancing lyso-
some biogenesis and activation (Samie and Cresswell, 2015).
Moreover, inhibiting endosome maturation with chloroquine
ameliorates cross-presentation (Accapezzato et al., 2005).
Further support is provided by the observation that cell surface
receptors retained longer in early endocytic compartments
may be more suitable for targeting antigens for efficient cross-
presentation than others rapidly trafficking to late compartmentsuthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
(Chatterjee et al., 2012; Cohn et al., 2013). This distinction may
also explain the relatively efficient cross-presentation of antigens
targeted to the mannose receptor (MR) traveling to early endo-
somes (Burgdorf et al., 2007).
Given the importance of DC-specific maturation kinetics for
cross-presentation, the mechanisms underlying have been
subject to significant scrutiny. These studies have uncovered a
number of features inhibiting the function or the recruitment to
maturing vesicles of late endosomes and lysosomes. These
include incomplete assembly of the proton pump V-ATPase
(Delamarre et al., 2005), recruitment of the alkalinizing NADPH
oxidase 2 (Savina et al., 2006), and lipopolysaccharide (LPS)-
induced, Rab34-dependent perinuclear clustering of lysosomes.
However, mechanisms regulating trafficking of early endosomes
and phagosomes have not been reported so far.
Understanding of physiological cell biological pathways has in
many instances benefitted from studying how pathogens sub-
vert such pathways. Because phagosome maturation results in
destruction of internalized pathogens, various microbes surviv-
ing and proliferating in intracellular vacuoles have developed
mechanisms to block maturation of early to late phagosomes.
One of these implicates Rab14, a small GTPase associated
with early endosomes, that is recruited by mycobacteria, salmo-
nella, legionella, and chlamydia to subvert phagosome matura-
tion through an unknown mechanism (Capmany and Damiani,
2010; Hoffmann et al., 2014; Kuijl et al., 2007; Kyei et al.,
2006). We investigated how Rab14 physiologically controls en-
dosome and phagosome maturation. Here we describe a com-
plete mechanism by which active Rab14 triggered by innate im-
mune stimuli recruits the kinesin KIF16b to endosomes, thereby
retaining incoming material in the cellular periphery, delaying
fusion with acidic degradative vesicles and ultimately regulating
cross-presentation.
RESULTS
Rab14 Highlights a Subpopulation of Early Endosomes
in DCs
Rab14 is expressed in most cell types including macrophages
and DCs. However, it has been studied most thoroughly in cells
expressing the Glut4 glucose transporter such as adipocytes
and muscle cells. In these cells, Glut4 localizes to a subpopula-
tion of endosomes known as Glut4 storage vesicles (GSVs)
(Rowland et al., 2011; Sadacca et al., 2013). Signaling by the in-
sulin receptor results in a rapid increase in Glut4 density at the
cell surface (Chen and Lippincott-Schwartz, 2013). Among
several Rab proteins regulating trafficking to and from GSVs,
Rab14 is thought to direct Glut4 from recycling endosomes
and/or the trans-Golgi network (TGN) to GSVs (Sadacca et al.,
2013). Thus, in muscle cells, Rab14 mediates retention of
cell-specific proteins in an endosomal storage compartment
(Jaldin-Fincati et al., 2017; Leto and Saltiel, 2012).
We wondered whether Rab14 might localize to a similar endo-
some subpopulation in DCs. In steady-state bone marrow-
derived DCs (BM-DCs), Rab14 co-localized strongly with insu-
lin-regulated aminopeptidase (IRAP), a hallmark constituent of
GSVs in Glut4-expressing cells (Figure 1A) (Keller, 2003).
Rab14 also co-localized strongly in peripheral endosomes, butnot in the TGN with syntaxin 6 (Stx6), a soluble N-ethylmalei-
mide-sensitive-factor attachment protein receptor (SNARE)
involved in trafficking between the TGN and endosomes, the
latter including GSVs (Du et al., 2014; Watson et al., 2008).
Therefore, BM-DCs harbor endosomes with a protein profile
resembling GSVs.
To further examine whether Rab14 localizes to general endo-
somes or to a GSV-like specific population, we knocked down
Rab14 and examined the effect on general and GSV-associated
endosome markers. Efficient knockdown of Rab14 (>70%
reduction; Figure 1B) strongly reduced staining for IRAP and
staining in the cellular periphery for Stx6 but had no notable ef-
fect on staining for early endosome antigen (EEA-1) or the MR,
or on Stx6 staining in the TGN (Figure 1C). Moreover, co-locali-
zation between EEA-1 and the MR was not affected, whereas
EEA-1 co-localization with Stx6 and IRAP, as well as MR co-
localization with IRAP, were almost abolished (Figure 1D). This
is consistent with the notion that Rab14 marks a specific subset
of endosomes. We concluded that, in DCs, Rab14 not only
marks a subtype of endosomes bearing GSV-associated
markers but also seems to be required for formation or stability
of these vesicles.
Effect of Rab14 on Phagosome Maturation and Cross-
Presentation
Given that Rab14 is recruited to various microbe-containing vac-
uoles, we reasoned that Rab14 recruitment might be a regular
event in DC phagosome maturation. To monitor phagosome
maturation, we developed a protocol in which recruitment of
EEA-1, Lamp1, and Rab14 to phagosomes of 1,000 BM-DCs
per time point is evaluated quantitatively by imaging flow cytom-
etry (Johansson et al., 2015) (Figures S1A–S1C). Using this
method, we observed transient recruitment of Rab14 to BM-
DCphagosomes at 20min after the end of phagosome formation
(Figure 1E).
Next, we examined the effect of Rab14 knockdown on phag-
osome maturation. Uptake of yeast was not affected by Rab14
knockdown (Figure S1D). In control cells, phagosomes initially
stained for EEA-1 and acquired Lamp1 only at 35 min (Fig-
ure 2A). In contrast, Rab14 knockdown accelerated EEA-1
loss and Lamp1 acquisition. Quantitative evaluation by imaging
flow cytometry confirmed EEA-1 loss starting at 30 min and
enhanced Lamp1 acquisition starting at very early time points
(Figure 2B). We concluded that low abundance of Rab14 results
in accelerated phagosome maturation (Figure S1E). Consistent
with this, killing of phagocytized P. aeruginosa was enhanced
(Figure 2C).
To study the impact of Rab14 on cross-presentation capacity,
we first used the model of HEK293 cells transfected with an Fc
receptor and the murine H-2Kb MHC class I molecule (Giodini
et al., 2009). These cells can cross-present immune complexes
formed between ovalbumin (OVA) and anti-OVA antibodies
that are internalized via the Fc receptor and degraded to the
SIINFEKL (S8L) OVA peptide presented by H-2Kb. Peptide pre-
sentation can be read out using OT-I T cell receptor transgenic
T cells (Hogquist et al., 1994) or the B3Z hybridoma. Rab14
knockdown by lentivirus transduction did not affect H-2Kb
expression or presentation of synthetic S8L by HEL cells orCell Reports 24, 3568–3581, September 25, 2018 3569
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Figure 1. Rab14 Highlights a Subpopulation
of Early Endosomes in DCs
(A) Expression and co-localization of Rab14
(endogenous or transfected as GFP fusion pro-
tein), Stx6, and IRAP in murine BM-DCs.
(B) Efficiency of Rab14 knockdown in BM-DCs as
judged by immunoblot.
(C) Co-localization of the markers indicated, in
BM-DCs transduced with control non-targeting
(shNT) or Rab14-targeting (shRab14) lentivirus.
(D) Quantitative analysis of the experiments shown
in (C) (n > 15 cells).
(E) Imaging flow cytometry analysis of Rab14
recruitment by phagosomes for shNT-transduced
BM-DCs.
All images and plots are representative of 3 ex-
periments. Scale bars, 5 mm. ****p < 0.0001.
Graphics show means ± SEM.BM-DCs (Figure S2A–S2C) but compromised cross-presenta-
tion of immune complexes by HEK293 cells (Figure 2D). Trans-
fecting transduced cells with a Rab14 cDNA not containing the
target sequence of the short hairpin RNA (shRNA) more than fully
restored cross-presentation, ruling out an off-target effect (Fig-
ure 2E). To further test the relationship between Rab14 expres-
sion and cross-presentation, we increased Rab14 expression
by transfecting a Rab14-mCherry fusion protein. Transfected
cells formed enlarged early endosomes staining for EEA-1,
IRAP, and Stx6, thus resembling GSV-like DC vesicles (Figures
S3A and S3B). Rab14 overexpression increased cross-presen-
tation of immune complexes (Figure 2F). Conversely, knock-
down of Rab14 in BM-DCs compromised cross-presentation
of both an OVA fusion protein targeted to the MR (Kratzer
et al., 2010) and yeast cells bearing OVA at the surface (Saveanu
and van Endert, 2013) (Figures 2G and 2H). We concluded that
the capacity to cross-present correlates with Rab14 expression
levels both in DCs and in non-professional antigen-presenting3570 Cell Reports 24, 3568–3581, September 25, 2018cells, and that the impact of Rab14 in
cross-presentation extends to particulate
and soluble receptor-targeted antigens.
Identification of the GTPase-
Activating Protein Regulating
Rab14
Rab GTPases are active when bound to
GTP and inactivated by GTPase-acti-
vating proteins (GAPs) (Stenmark, 2009).
Given the rarity of Stx6+IRAP+ endo-
somes observed upon Rab14 knock-
down, it was possible that the effect of
Rab14 on phagosome maturation was
due to a structural role rather than to
recruitment of an effector by its active
form. To differentiate between these two
modes of action, we set out to identify a
Rab14-specific GAP expressed in DCs
and to test its impact. If Rab14 had a
mere structural role, it was less likely tobe dependent on an intact nucleotide exchange cycle. In adipo-
cytes and skeletal muscle, Tbc1d1 and Tbc1d4/AS160 act as
GAPs for several Rab proteins including Rab14 (Sakamoto and
Holman, 2008). Published microarray data suggest that DCs
and macrophages express more Tbc1d4 than Tbc1d1 (https://
www.immgen.org). We analyzed endosomes in BM-DCs
lacking Tbc1d1, Tbc1d4, or both GAPs (Chadt et al., 2015) (Fig-
ures 3A–3D). In wild-type (WT) but also in Tbc1d1 knockout
(KO) cells, Rab14+Stx6+ vesicles belonged to early endosomes
as documented by partial staining for EEA-1 and absence of
Lamp1 staining. In contrast, absence of Tbc1d4 resulted in for-
mation of enlarged Rab14+Stx6+ endosomes displaying reduced
co-localization with EEA-1 and partial co-localization with
Lamp1. Tbc1d4 could also be co-precipitated with IRAP, consis-
tentwith its recruitment toRab14+ endosomes andwith observa-
tionsmade in adipocytes (Rowlandet al., 2011) (Figure 3E). These
observations indicate that Tbc1d4 is a GAP for Rab14 in BM-
DCs. Moreover, they suggest that the balance between the
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Figure 2. Rab14 Knockdown Accelerates
Phagosome Maturation and Compromises
Cross-Presentation
(A) BM-DCs transduced with control non-targeting
(shNT) or shRab14 lentiviruses were pulsed with
S. cerevisiae for 5 min and incubated at 37C for
the indicated periods of time before staining for
EEA-1 and Lamp1.
(B) Imaging flow cytometry analysis of EEA-1 and
Lamp1 recruitment for shNT and shRab14-trans-
duced BM-DCs.
(C) Survival, as determined by colony formation
assay, of Pseudomonas aeruginosa phagocy-
tosed by shRNA-transduced BM-DCs.
(D) HEK293 cells transduced with lentiviruses
were pulsed with OVA-anti-OVA immune com-
plexes and used to stimulate B3Z hybridoma cells.
Stimulation was read out as IL-2 secretion by
ELISA.
(E) HEK293 cells were sequentially transduced
with Rab14 shRNA and transfected with Rab14-
mCherry before analyzing presentation of immune
complexes.
(F) HEK293 cells were transfected with a plasmid
expressing Rab14-mCherry or an empty vector-
mCherry, and cross-presentation of OVA-anti-
OVA complexes was analyzed as in (D).
(G and H) Lentivirus-transduced BM-DCs were
pulsed with an OVA fusion protein targeted to the
MR (left panel) (G) or with OVA-yeast cells (H) and
then added to OT-I cells. Activation of OT-I CD8+
cells was read out as IL-2 secretion by ELISA.
All images and plots are representative of 3 or 2 (B)
experiments. *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001. Graphs show mean ± SEM.GTP- and GDP-bound states of Rab14 is important for the phys-
iological trafficking of Rab14+Stx6+IRAP+ endosomes. However,
when we tested cross-presentation of MR-targeted or yeast-
decorating OVA by BM-DCs lacking either or both of the GAPs,
absenceof Tbc1d4enhancedcross-presentation of both antigen
forms (Figure 3F). Tbc1d4 KO also enhanced cross-presentation
by inflammatory DCs (Cheong et al., 2010), the cells correspond-
ing most closely to BM-DCs, produced in vivo by injection with
LPS and soluble OVA, and tested ex vivo (Figure 3G). Therefore,Cell Reportsa shift to the GTP-bound state of Rab14
promotes cross-presentation.
We also examined the effect of muta-
tions locking Rab14 in the GTP- or
GDP-bound state on endosome forma-
tion and cross-presentation. Transfection
of Rab14 had no notable effect on BM-
DC differentiation or activation, as docu-
mented by an unchanged proportion of
CD11c+CD11b+ cells in cultures and
identical CD80 expression (Figures S4A
and S4B). Overexpressed WT Rab14
was found in enlarged endosomes
and co-localized normally with Stx6 and
IRAP, but not Lamp1 (Figures S4C and
S4D). In contrast, the GTP-locked mutantQ70L showed reduced co-localization with Stx6 and IRAP, and
enhanced co-localizationwith Lamp1, thus resembling the distri-
bution of endogenous Rab14 in Tbc1d4 KO BM-DCs. The GDP-
locked mutant S25N completely lacked co-localization with
IRAP and co-localized only with Golgi-resident Stx6, consistent
with retention in the Golgi and early secretory pathway, as re-
ported previously (Junutula et al., 2004) (Figures S4C and
S4D). In a cross-presentation assay, overexpression of WT
Rab14 slightly enhanced cross-presentation, whereas not only24, 3568–3581, September 25, 2018 3571
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Figure 3. Tbc1d4 Is the GAP for Rab14 in DCs
and Regulates Cross-Presentation
(A and B) Tbc1d1- or Tbc1d4-deficient BM-DCs
were stained for Stx6 and EEA-1 (A), or for Rab14
and Lamp1 (B). The dotted boxes enclose the areas
shown as split images below the larger images.
(C and D) Quantitative analysis of co-localization
(n = 10 cells) of EEA1with Stx6 (C) and of Rab14with
Lamp 1 (D) in WT BM-DCs and DCs lacking Tbc1d1,
Tbc1d4, or both (D1D4KO).
(E) Immunoprecipitation of Tbc1d4 and IRAP from
WT or IRAP KO BM-DCs followed by immunoblot
analysis of IRAP co-precipitation.
(F) Cross-presentation of MR-targeted OVA (left
panel) and OVA-expressing yeast cells (right panel)
to OT-I T cells by WT, Tbc1d1 KO, Tbc1d4 KO, and
double-KO BM-DCs.
(G) WT and Tbc-deficient mice were first injected
with LPS and then with OVA 2 hr before isolation of
inflammatory DCs. DCs were added to dye-labeled
OT-I at 1:3, and proliferation was measured after
3 days.
The experiments shown are representative of 3
(C) or 2 experiments. *p < 0.05; **p < 0.01; ***p <
0.001; ****p < 0.0001. Scale bar, 5 mm. Graphs show
means ± SEM.
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GDP-locked, as expected, but surprisingly also GTP-locked
Rab14 compromised it in both BM-DCs and HEK293 cells (Fig-
ures S4E and S4F). Therefore, although shifting Rab14 to the
GTP-bound state either through the Q70L mutation or through
deletion of the Tbc1d4 GAP has very similar effects on Rab14
trafficking, the effects on cross-presentation differ markedly,
presumably because of the inability of the mutant to hydrolyze
GTP, which therefore is critical for cross-presentation.
Rab14 Interacts with a Kinesin
How does GTP-bound Rab14 promote cross-presentation? Rab
GTPases act by recruiting effector proteins upon activation
(Stenmark, 2009). Among these are motor proteins for microtu-
bule transport. In most cells, kinesins mediate anterograde
transport to the cell periphery and dynein retrograde centripetal
transport to the microtubule organizing center (Hancock, 2014).
Given that late endosomes and phagosomes accumulate at the
cell center, we speculated that Rab14 interaction with a kinesin
might delay endosome and phagosome contact with degrada-
tive vesicles, thus favoring cross-presentation. We tested our
hypothesis first in Rab14-transfected embryonal fibroblasts
strongly expressing Rab14+Stx6+IRAP+ vesicles (Figure S3C).
We analyzed a potential interaction between Rab14 and kinesins
using the proximity ligation assay (PLA) that detects proximity of
proteins 40 nm or less distant from each other. PLA analysis us-
ing a pan-kinesin and a Rab14 antibody revealed proximity be-
tween Rab14 and one or several kinesins (Figures 4A and 4B).
In Rab14/GFP-transfected HEK293 cells expressing an Fc re-
ceptor, Rab14-kinesin proximity was also present at the steady
state and strongly enhanced upon immune complex binding to
Fcg receptors (Figures 4C and 4D). Control immunoglobulins
combined with Rab14 antibodies did not give a PLA signal in
transfected MEFs or HEK293 cells. To further test the specificity
of the PLA signal, we performed an analysis using a pan-kinesin
antibody combined with antibodies recognizing the three hall-
mark proteins of the GSV-like vesicles, Rab14, Stx6, and IRAP
in BM-DCs. A PLA signal was obtained using only Rab14 anti-
bodies, consistent with specific recruitment of a kinesin by the
GTPase (Figure 4E). Incubation of BM-DCs with LPS for 1 hr
increased this PLA signal (Figures 4F and 4G). In cells lacking
the Rab14 GAP Tbc1d4, both the number of PLA dots and the
endosome diameter were increased at steady state and upon
LPS incubation, consistent with a role for GTP-bound Rab14 in
kinesin interaction (Figures 4H–4J). We concluded that Rab14
is likely to recruit a kinesin as effector protein, and that this
recruitment is stimulated by innate immune signaling through
toll-like receptor 4 (TLR4) or Fc receptors.
Dynein-Mediated Retrograde Transport Compromises
Cross-Presentation
Our finding of Rab14-kinesin proximity suggested that antero-
grade vesicle transport promoted cross-presentation. Reasoning
that retrograde transport mediated by dynein might therefore
reduce cross-presentation efficacy, we knocked down dynein
heavy chain (Figure 5A) and examined the effect on Rab14+ endo-
somes and on cross-presentation. Knocking down dynein did not
affect Rab14+Stx6+ endosomes inWTDCs (Figure 5B) or presen-
tation of synthetic peptide S8L by them (Figure S2D). This was notsurprising given thatWTRab14 co-localizes very little with Lamp1
(Figure 3D), suggesting a physiological dominance of anterograde
over retrograde transport of Rab14+ vesicles. We reasoned that
the effect of retrograde transport on Rab14+ endosomes and
cross-presentation might become evident in conditions destabi-
lizing these vesicles.
We have recently described that IRAP stabilizes Stx6+ endo-
somes due to interaction with the actin-nucleation factor
FHOD4, resulting in partial depletion of these vesicles in IRAP-
deficient cells (Babdor et al., 2017). Like Rab14 knockdown
DCs, these cells display unperturbed co-localization of EEA-1
and MR in early endosomes but low co-localization of Stx6
with each of these markers; as a result of the depletion of
IRAP+ endosomes, Rab14+EEA-1+ endosomes are virtually ab-
sent (Figure S5). In IRAP KO BM-DCs, Rab14 failed to be re-
cruited to early phagosomes, and phagosomes displayed early
loss of EEA-1 combined with accelerated acquisition of Lamp1
(Figure S6A). Moreover, Rab14 knockdown had no effect on
the kinetics of maturation of phagosomes in IRAP KO cells
(Figure S6B, left panel). Taken together, these findings suggest
overlapping effects of Rab14 knockdown and IRAP KO on the
GSV-like vesicles.
To assess the role of microtubule transport on Rab14+ vesi-
cles, we first examined the effect of paclitaxel (Taxol) that inhibits
microtubule disassembly on Rab14+ endosomes in WT and
IRAP KO DCs. Microtubule stabilization had little effect on
Rab14+ endosomes in WT DCs but restored these vesicles in
IRAP KO cells (Figure 5C). Paclitaxel also restored endogenous
Rab14 proximity with kinesin that was absent in untreated
IRAP KO DCs, as measured by PLA (Figure 5E). In WT and
IRAP KO fibroblasts transfected with Rab14-GFP, a pan-kinesin
antibody co-precipitated Rab14, indicating that this PLA signal
was due to physical interaction (Figure 5D). We concluded that
depletion of Rab14+ endosomes and of Rab14-kinesin interac-
tion in IRAP KO cells depended on microtubule transport.
Knockdown of dynein in IRAP KO BM-DCs indeed restored
endosomes staining for Rab14 and Stx6, analogous to the effect
of paclitaxel (Figure 5F). In IRAP KO cells depleted for dynein,
Rab14 recruitment to phagosomes was restored, whereas
Lamp1 recruitment and phagosome maturation were delayed
(Figures 5G and S6B, center panel). Remarkably, dynein deple-
tion fully normalized cross-presentation of both MR-targeted
and yeast-decorating OVA by DCs, while increasing cross-pre-
sentation by WT cells only slightly (Figure 5H). Two additional
shRNA sequences targeting dynein also restored cross-presen-
tation, to an extent reflecting the magnitude of their effect on
dynein expression (Figures S6C–S6E). Collectively, these data
suggest that Rab14+Stx6+ endosomes are formed in IRAP KO
cells and can promote cross-presentation but are destabilized
by loss of the IRAP-formin anchor, resulting in dominant retro-
grade transport presumably followed by dissociation or degra-
dation of Rab14.
Identification of the Kinesin Effector Protein Interacting
with Rab14
Finally, we sought to identify the kinesin(s) interacting with
Rab14. A literature search identified KIF16B, a member of the ki-
nesin 3 family, as the single kinesin protein described as Rab14Cell Reports 24, 3568–3581, September 25, 2018 3573
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Figure 4. DC Rab14 Interacts with a Kinesin
(A) PLA on Rab14-GFP-transfected MEFs with Rab14 antibodies or control IgG together with pan-kinesin antibodies.
(B) Quantification of the PLA signal forR30 cells per group obtained in the experiment shown in (A).
(C) PLA analysis of Rab14/kinesin proximity in CD32a-expressing HEK293 cells stimulated with OVA-IgG immune complexes for the periods indicated.
(D) Quantitative evaluation of (C), as in (B).
(E) Analysis of Rab14-kinesin proximity to Rab14, Stx6, and IRAP in BM-DCs.
(F) PLA analysis of BM-DCs stimulated or not for 1 hr with LPS.
(G) Quantitative evaluation of the PLA analysis in (F), performed as in (B).
(H) PLA analysis of Rab14-kinesin interaction in WT and Tbc1d4-deficient BM-DCs stimulated or not for 1 hr with LPS (n = 14 cells per group).
(I) Quantitative evaluation of the PLA analysis in (H).
(J) Quantification of PLA dot diameter (mm) for LPS-treated WT and Tbc1d4-deficient BM-DCs.
All experiments were performed at least twice. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Scale bars, 5 mm. Graphs show means ± SEM.
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Figure 5. Rab14+IRAP+ Endosomes Inhibit
Minus-End Microtubule Vesicle Transport
Compromising Cross-Presentation
(A) The efficiency of lentivirus-mediated shDHC
knockdown in WT and IRAP KO BM-DCs was
analyzed by immunoblot for dynein intermediate
chain (DIC), which is destabilized in the absence
of dynein heavy chain (DHC).
(B) Effect of DHC knockdown on subcellular dis-
tribution of Rab14, GM130, Stx6, and EEA1 inWT
BM-DCs.
(C) Effect of microtubule stabilization by pacli-
taxel on the subcellular distribution of Rab14,
tubulin, and EEA-1 in WT and IRAP KO cells. The
dotted boxes enclose the areas shown as split
images below the larger images.
(D) Kinesin heavy chain was immunoprecipitated
from MEFs transfected or not with Rab14-GFP
and analyzed for co-precipitation of Rab14 by
immunoblot.
(E) PLA analysis of Rab14/pan-kinesin proximity
in BM-DCs treated with paclitaxel for 1 hr.
(F) Effect of DHC knockdown on the subcellular
distribution of Rab14, GM130, Stx6, and EEA1 in
IRAP KO BM-DCs.
(G) Mean fluorescence intensity for EEA-1,
Lamp1, and Rab14 at the phagosome membrane
for control non-targeting (shNT) or shDHC-
transduced BMDCs, determined by imaging flow
cytometry. For easier readability, each dot rep-
resents the mean of 50 cells; statistical evaluation
was performed on 1,000 individual BMDCs.
Black line represents mean value.
(H) Cross-presentation of MR-targeted OVA and
of OVA-expressing yeast cells by BM-DCs
transduced with control or DHC-targeting shRNA
was assessed using OT-I T cells.
All experiments were performed at least
twice, with analysis of 10 cells per condition for
microscopy experiments. *p < 0.05; **p < 0.01;
****p < 0.0001. Scale bar, 5 mm. Graphs show
means ± SEM.
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effector. KIF16B mediates Golgi to endosome transport of fibro-
blast growth factor in mouse embryos (Ueno et al., 2011). It also
relocates early endosomes to the periphery and inhibits their
transport to the degradative pathway in HeLa cells (Hoepfner
et al., 2005). Knockdown of Kif16b reduced its expression in
HEK293 cells and BM-DCs by 75% (Figures 6A and 6B). Deple-
tion of KIF16B in BM-DCs abolished peripheral clustering of
Rab14+ and IRAP+ endosomes, instead scattering small endo-
somes across the entire cell, consistent with an interaction be-
tween Rab14 and KIF16B in BM-DCs (Figure 6C).
Lack of commercial antibodies suitable for immunoprecipita-
tion of KIF16B or for a PLA analysis precluded obtaining direct
evidence for this interaction. However, we reasoned that, if
KIF16B was the principal kinesin interacting with Rab14, then
knocking it down should strongly reduce the PLA signal obtained
using pan-kinesin combined with Rab14 antibodies. Indeed,
KIF16B depletion from HEK293 cells essentially abolished kine-
sin-Rab14 interaction at the steady state, as well as its increase
triggered by immune complex binding in a PLA analysis (Fig-
ure 6D). Knockdown of KIF16B (like that of dynein) did not affect
yeast uptake or presentation of synthetic peptide S8L by BM-
DCs (Figures S2E, S7A, and S7B). Imaging flow cytometry
demonstrated that KIF16B depletion abolished recruitment of
Rab14 to phagosomes and accelerated their maturation, as re-
flected in accelerated loss of EEA-1 and acquisition of Lamp1
(Figures 6E and S7C). Indicative of an important role of the
Rab14-KIF16B interaction in cross-presentation, Kif16b knock-
down reduced cross-presentation of receptor-targeted and
phagocytized antigen (Figure 6F) by BM-DCs, as well as cross-
presentation of immune complexes by HEK293 cells (Figure 6G).
In contrast, it did not further compromise cross-presentation by
IRAP KO DCs (Figure 6F), a finding consistent with a model in
which the impact of KIF16B depends entirely on its interaction
with Rab14, which itself has no additive effect in IRAP KO BM-
DCs (Figure S6B). Finally, consistent with the PLA analysis
shown in Figures 4H–4J, an in vitro assay demonstrated exclu-
sive KIF16B interaction with the GTP-locked form of Rab14
(Figure 6H).
DISCUSSION
This study reports three principal findings. First, we identify a
critical role in cross-presentation of a small GTPase previously
linked to GSV trafficking in adipocytes and muscle cells, and to
establishment of microbe vacuoles in macrophages. Second,
we determine the mechanism underlying this role, which impli-
cates anterograde vesicle transport on microtubules. Finally,
we identify KIF16b as the main kinesin mediating this transport.
Collectively, our results suggest a scenario (Figure 7) in which
BM-DC Rab14+Stx6+IRAP+ vesicles are recruited to internalized
material early after receptor-mediated endocytosis or phagocy-
tosis. Innate immune signaling downstream of Fc receptors and
TLR4 phosphorylates and inactivates Tbc1d4, thus activating
Rab14, which binds KIF16B upon GTP binding. KIF16B/Rab14
complexes then mediate dominant anterograde transport
of endosomes and/or phagosomes, thereby delaying fusion
with lysosomes and antigen degradation and promoting cross-
presentation.3576 Cell Reports 24, 3568–3581, September 25, 2018The favorable role of an ‘‘early endosome’’ environment in
cross-presentation is an accepted concept in the field. However,
in contrast to the common concept defining this environment
as EEA-1+ vesicles, we show that such a favorable environ-
ment depends on a subtype of early endosomes defined by
Rab14+IRAP+Stx6+. Compromising this subpopulation does
not affect EEA-1+MR+ early endosomes but is sufficient to alter
endosome maturation and cross-presentation. Our findings
emphasize the dynamic nature of these vesicles that must be
maintained by activemicrotubule transport, which in turn is regu-
lated by innate immune signaling. The standard time span for
early to late endosomematuration is estimated at 8–15min (Huo-
tari and Helenius, 2011), a duration likely insufficient for antigen
degradation, transport, and loading on MHC class I molecules.
Therefore, trafficking pathways delaying early endosome matu-
ration and/or sorting early endosome cargo to slowly maturing
vesicles are a requirement for efficient cross-presentation.
Knockdown of Rab14 resulted in strongly reduced abundance
of Stx6+IRAP+ endosomes. This is likely due to rapid retrograde
transport of these endosomes. The directional outcome of
microtubule transport depends on the balance of recruitment
of effectors mediating anterograde and retrograde transport; ef-
fectors mediating transport in the two directions may be re-
cruited by distinct GTPases or by the same GTPase, as is the
case for Rab7 (Wijdeven et al., 2015). Analysis of IRAP KO cells
allowed us to directly demonstrate that ‘‘disappearance’’ of
Stx6+ endosomes was due to dynein-mediated retrograde
microtubule transport. Given that the effect of IRAP KO was
indistinguishable from that of Rab14 knockdown with respect
to the abundance of Stx6+ endosomes and to phagosomematu-
ration, and that Rab14 knockdown had no effect on phagosome
maturation in IRAP KO cells, it is reasonable to assume that the
dearth of Stx6+ endosomes observed upon Rab14 knockdown
was due to the same mechanism. This notwithstanding, the
available evidence indicates that the cell biological effects
through which IRAP KO and Rab14 knockdown confer unop-
posed dominance to the retrograde transport of Stx6+ endo-
somes are different: while IRAP KO removes static anchoring
of the vesicles to the actin cytoskeleton through a formin,
Rab14 knockdown removes dynamic anterograde transport.
As previously reported by us, IRAP also has an additional func-
tion as trimming peptidase (Saveanu et al., 2009). Our unpub-
lished data suggest that this function is not dispensable,
because reconstitution of IRAP KO BM-DCs with protease-
dead IRAP reconstitutes Stx6+ endosomes but not cross-pre-
sentation fully.
Our observations led us to conclude that the effect of Rab14
on phagosome maturation and cross-presentation is due to its
ability to recruit KIF16B. Studying how Salmonella entericamod-
ulates vacuole maturation in a Rab14-dependent manner to pro-
mote its survival, Kuijl et al. (2013) identified its interaction with
the dual effector Nischarin that directs maturation to Rab9+ as
opposed to Rab7+ late endosomes. However, we did not
observe any effect of Rab9 knockdown on cross-presentation
(S. Montealegre and P.v.E., unpublished data), suggesting that
the pathway proposed by these authors modulates pathogen
survival, but not cross-presentation. We could obtain indirect
but strong evidence for Rab14-KIF16B proximity at endosomes,
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Figure 6. Rab14-KIF16B Interaction Delays PhagosomeMatura-
tion and Promotes Cross-Presentation
(A) Immunoblot showing expression of KIF16B by HEK293 cells ex-
pressing CD32a transduced with control or KIF16B-specific shRNA.
(B) KIF16B mRNA expression in BM-DCs transduced with specific
shRNA, as percentage of expression in control non-targeting (shNT)-
transduced cells.
(C) Expression and co-localization of indicated markers in BM-DCs
transduced with non-targeting or KIF16B-specific shRNA.
(D) PLA analysis of Rab14/pan-kinesin proximity in CD32a-expressing
HEK293 cells transduced with control or KIF16B-specific shRNA and
stimulated with OVA-anti-OVA immune complexes for the indicated time
periods. Quantitative evaluation ofR30 cells per condition on the right.
(E) Imaging flow cytometry analysis of EEA-1, Rab14, and Lamp1
recruitment to phagosomes by shNT or shKIF16B-transduced BM-DCs.
Representation as in Figure 3G.
(F) Cross-presentation of MR-targeted OVA and OVA-expressing yeast
cells by BM-DCs transduced with control or KIF16b-targeting shRNA was
assessed using OT-I T cells.
(G) Cross-presentation of OVA-anti-OVA immune complexes by HEK293
cells transduced with control or KIF16B-specific shRNA.
(H) In vitro interaction of KIF16B-YFP with WT, GTP-locked (Q70L), and
GDP-locked (S25N) Rab14-mCherry. Rab14 proteins were immunopre-
cipitated by incubating lysates from single-transfected HEK cells (right-
hand lanes) with KIF16B-YFP trapped on anti-GFP beads. The control
(Ctr) represents the background of GTP-locked Rab14-mCherry binding
to GFP-trap beads.
All experiments were performed at least twice. *p < 0.05; **p < 0.01; ***p <
0.001; ****p < 0.0001. Scale bar, 5 mm. Graphs show means ± SEM.
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Figure 7. Role of Rab14 in Endosome
Transport and Antigen Cross-Presentation
(A) In WT DCs, TLR4 or FcR activation triggers
Rab14 interaction with KIF16B, thereby mediating
the anterograde transport of endosomes along
microtubules and their fusion with early phag-
osomes. Phagosomal recruitment of Rab14 de-
lays phagosome maturation and pathogen killing.
IRAP in Rab14 endosomes trims peptides to the
correct length for MHC class I binding and also
contributes to stabilization of early phagosomes
by interaction with the actin remodeling protein,
FHOD4.
(B) Overexpression of WT Rab14, inhibition of
retrograde transport by dynein, knockdown, or
shifting Rab14 to the GTP-bound form by deletion
of Tbc1d4 enhance the anterograde transport of
endosomes and upregulate cross-presentation.
(C) Conversely, the depletion of Rab14 or KIF16B
shifts the equilibrium to retrograde transport of
endosomes, accelerates the phagosome fusion
with the late endosomes, and compromises anti-
gen cross-presentation.and direct evidence for a requirement of KIF16B for normal
phagosome maturation and cross-presentation. We cannot
rule out that KIF16B is required for early endosome positioning
to the cellular periphery, facilitating Rab14 recruitment to
phagosomes, which alone might promote cross-presentation.
However, endosome and phagosome maturation are known
to undergo similar events including microtubule transport
(Flannagan et al., 2012). Therefore, the Rab14-KIF16B interac-
tion is likely to be involved also in phagosome maturation.
Recruitment of KIF16B to endosomes was enhanced by
signaling through Fc receptors and TLR4, both known to
enhance cross-presentation (Joffre et al., 2012). Although study-
ing the signaling pathways involved would have overstepped the
context of this report, some reasonable assumptions can be
made in view of the literature. Both TLR4 and Fc receptors
can signal through the phosphoinositide 3-kinase (PI3K)/Akt
pathway (Nair et al., 2011). In adipocytes and muscle cells,
Tbc1d4, also known as Akt substrate of 160 kDa (AS160), is
phosphorylated and thereby inactivated upon signaling by the
insulin receptor through the PI3K/Akt pathway (Sadacca et al.,
2013). Inactivation of the Tbc1d4 GAP in turn activates its sub-
strates, among them Rab14. It is easily conceivable that
signaling downstream of PI3K/Akt follows a similar pathway in
BM-DCs. In support of this, Tbc1d4 KO not only enhanced
cross-presentation suggestive of a positive effect on Rab143578 Cell Reports 24, 3568–3581, September 25, 2018function, but also resulted in a partial
change of intracellular Rab14 localization
identical to that characterizing the consti-
tutively active Rab14 mutant Q70L,
strongly suggesting that Tbc1d4 sup-
ports the Rab14 active cycle. We found
enhanced cross-presentation ex vivo
by Tbc1d4-deficient monocyte-derived
DCs, the DC type resembling BM-DCs
most. Public RNA-sequencing (RNA-seq) and microarray data (https://www.immgen.org) document
limited expression of Tbc1d4 with high expression levels in
cDC1 and cDC2, suggesting a broader impact of this GAP in
cross-presentation in vivo.
The Q70L mutant and the GAP KO shared a partial endosomal
co-localization with Lamp1 not observed for endogenous or
overexpressedWT Rab14. This was at first sight surprising given
that in phagosome maturation, Lamp1 acquisition was inversely
correlated with cross-presentation efficacy. However, the pres-
ence of Lamp1 in a vesiclemay not always indicate its nature as a
late endosome or lysosome. Studying cells overexpressing
Rab14Q70L by electron microscopy, Junutula et al. (2004) pro-
posed that the mutant may localize to tubulo-vesicular transport
intermediates between the Golgi and endosomes. Electron
or super-resolution microscopy will have to reveal whether
Rab14Q70L localizes to similar vesicles in DCs. Another inter-
esting finding in this study is the discrepancy between the effects
of the Q70L mutant and the Tbc1d4 KO on cross-presentation
that contrasts with their similar effects on steady-state endoso-
mal distribution of Rab14. This observation must indicate that
the cycle of GTP hydrolysis and re-binding by Rab14 is not rele-
vant for endosomal Rab14 localization at steady state but essen-
tial for the role of Rab14 in cross-presentation.
In summary, we have demonstrated the important role of
innate receptor-triggered anterograde endosome transport
mediated by the Rab14-KIF16B interaction in cross-presenta-
tion. This mechanism complements previously reported mecha-
nisms, such as central lysosome clustering and phagosomal pH
control, and ensures prolonged maintenance of a vesicular envi-
ronment preventing premature antigen destruction. Whether the
mechanism described here also promotes other key steps in
cross-presentation such as antigen export to the cytosol, and
how it is related to other parameters such as MHC class I traf-
ficking and recycling, will be interesting questions for future
studies.
EXPERIMENTAL PROCEDURES
Mice
Previously described IRAP KO (Keller et al., 2002) and RAG-deficient OT-I
mice were bred in our animal facility. Mice lacking Tbc1d1/d4 were also
described previously (Chadt et al., 2015). The experiments were conducted
with male or female mice, 8–12 weeks old, weighing 20–25 g, and housed
under specific pathogen-free conditions in our animal facilities at 22C ± 2C
with a 12-hr light-dark cycle, with access to food and water ad libitum. All an-
imal care and experimental procedures were performed in accordance with
the guidelines and regulations of the French Veterinary Department and
approved by the Comite´ d’E´thique pour l’Expe´rimentation Animale Paris
Descartes (n P2.LS.156.10).
Cells
BM-DCs were obtained by culturing bone marrow cells in GM-CSF-containing
supernatant from J558 cells (Weimershaus and van Endert, 2013). HEK293-
FcR cells were a gift from P. Cresswell (Giodini et al., 2009), and the B3Z hy-
bridoma a gift of N. Shastri.
Fluorescence Microscopy
For analysis of the steady state, the cells were plated on fibronectin-coated
coverslips or on micro-pattern slides. For phagocytosis monitoring, cells
seeded in IbiTreat channels (BioValley) were pulsed with latex beads (Poly-
sciences) or yeast expressing OVA (Saveanu and van Endert, 2013). Images
were acquired with Leica SP8 or Zeiss LSM800 microscopes, equipped with
403 and 633 oil immersion objectives, respectively.
Image Analysis
Marker co-localization and signal intensity were evaluated using the
IMARIScoloc module for cells polarized on micro-patterns and with
ImageJ for other images. For each image, a stack of at least 10 planes
was acquired.
Cross-Presentation Assays
BM-DCs on day 7 were pulsed with preformed complexes of MR antibodies
with P3UO fusion protein (Kratzer et al., 2010) or yeast OVA, before
addition of OT-I cells for 20 hr. Where mentioned, cells were nucleofected
2 days before the assay with Rab14-GFP plasmids and sorted as
CD11c+CD11b+GFP+ cells or transduced with lentiviruses. HEK293 cells
were incubated with complexes of polyclonal mouse IgG and P3UO, option-
ally after transfection or lentiviral transduction 2 days prior to the assay, and
fixed before addition of B3Z cells. T cell stimulation was read out by
interleukin-2 (IL-2) sandwich ELISA. Ex vivo cross-presentation by mono-
cyte-derived DCs primed with OVA and LPS in vivo was analyzed adopting
a published protocol (Cheong et al., 2010).
Lentivirus Production and Transduction
Viruses were produced using standard protocols (Tiscornia et al., 2006) and
pLKO.1 plasmids obtained from Open Biosystems, plasmids packaging
pCMVDelta8.2, and envelope pMD2G and HEK293 cells. Infection of BM-
DCs and HEK cells was performed 4 days before assays (day 3 for BM-DCs)
with an MOI of 10, followed by puromycin selection.Proximity Ligation Assays
Duolink (OLINK Biosciences) assays were performed following entirely the
manufacturer’s instructions.
Phagosome Maturation Assay
Phagosome maturation was evaluated by imaging flow cytometry adopting a
published protocol (Johansson et al., 2015), with some modifications detailed
in the Supplemental Information. Images were acquired on an ImageStreamX
MkII machine (Amnis).
Co-precipitation and Immunoblots
Co-precipitation of IRAP and Tbc1d4, and of Rab14-GFP with kinesin, was
performed using standard protocols and 1% Triton X-100. To analyze
KIF16B interaction with Rab14 variants, HEK293 cells were separately trans-
fected with KIF16B-YFP and Rab14-mCherry. Three days later, CHAPS ly-
sates of KIF16B-YFP containing cells were incubated with GFP-trap beads
(Chromotek), followed by addition of lysates containing Rab14-mCherry. Elu-
ates in sample buffer were analyzed by immunoblots. All immunoblots were
performed using transfer in 10 mM N-cyclohexyl-3-aminopropanesulfonic
acid (CAPS) (pH 11) buffer to Immobilon membranes (Millipore). Proteins
were visualized using an enhanced chemiluminescence (ECL) system or the
Odyssey LI-COR imaging system and appropriate secondary antibodies.
Statistical Analysis
Values are expressed as mean ± SEM, unless otherwise specified. Statistical
significance between two groups was analyzed using the unpaired Student’s t
test, or the Mann-Whitney U test in image analysis experiments, whereas the
two-way ANOVA test with a Bonferroni post-test adjusted for multiple compar-
isons was used in in vitro and ex vivo experiments evaluating antigen presen-
tation and phagosome maturation by imaging flow cytometry. p values are
indicated as: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. GraphPad Prism
version 6.0 was used to perform the statistical analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2018.08.041.
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